Cargando…
Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox
BACKGROUND: Resistance to chemotherapy is the major cause of failure in breast cancer treatment. Recent studies suggest that secreted proteins may play important roles in chemoresistance. We sought to systematically characterize secreted proteins associated with drug resistance, which may represent...
Autores principales: | Yao, Ling, Zhang, Yan, Chen, Keying, Hu, Xiaofang, Xu, Lisa X. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169632/ https://www.ncbi.nlm.nih.gov/pubmed/21931812 http://dx.doi.org/10.1371/journal.pone.0024684 |
Ejemplares similares
-
Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2019) -
Evaluation of the Anticancer Activity of Calcium Ions Introduced into Human Breast Adenocarcinoma Cells MCF-7/WT and MCF-7/DOX by Electroporation
por: Bieżuńska-Kusiak, Katarzyna, et al.
Publicado: (2023) -
Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
por: Wang, Xu, et al.
Publicado: (2020) -
A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression
por: Wang, Ting, et al.
Publicado: (2021) -
Revealing Glycoproteins in the Secretome of MCF-7 Human Breast Cancer Cells
por: Tan, Aik-Aun, et al.
Publicado: (2015)